![Armin W. Mäder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Armin W. Mäder
Founder at Qvanteq AG
Armin W. Mäder active positions
Companies | Position | Start | End |
---|---|---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Director of Finance/CFO | 04/11/2009 | - | |
Qvanteq AG
![]() Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Chairman | 01/01/2009 | - |
Founder | 01/01/2009 | - |
Career history of Armin W. Mäder
Former positions of Armin W. Mäder
Companies | Position | Start | End |
---|---|---|---|
AC IMMUNE SA | Chief Operating Officer | - | - |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Chief Executive Officer | - | - |
Chairman | - | - | |
Institut Straumann AG
![]() Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Director of Finance/CFO | - | - |
Training of Armin W. Mäder
International Institute for Management Development | Masters Business Admin |
Swiss Federal Institute of Technology | Doctorate Degree |
Statistics
International
Switzerland | 8 |
Operational
Chief Executive Officer | 2 |
Director of Finance/CFO | 2 |
Chairman | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Private companies | 4 |
---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Institut Straumann AG
![]() Institut Straumann AG Medical/Nursing ServicesHealth Services Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland. | Health Services |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Health Technology |
Qvanteq AG
![]() Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Armin W. Mäder
- Experience